/OCPNF

OCPNF Stock - Olympus Corporation

Q: What is the analyst price target for OCPNF?

Analyst price target information is not currently available for OCPNF.

Q: What is OCPNF's market cap?

Market capitalization information is not currently available for OCPNF.

Healthcare|Medical - Instruments & Supplies|OTC

$12.50+8.32%

+$0.96 (+8.32%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $13.75

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for OCPNF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.34

52W High$15.50

52W Low$10.89

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$997.33B	$936.21B	$881.92B	$868.87B	$730.54B
Gross Profit	$683.70B	$625.12B	$562.70B	$475.99B	$427.99B
Gross Margin	68.6%	66.8%	63.8%	54.8%	58.6%
Operating Income	$162.46B	$151.89B	$186.61B	$166.30B	$102.50B
Net Income	$117.86B	$242.57B	$143.43B	$115.74B	$12.92B
Net Margin	11.8%	25.9%	16.3%	13.3%	1.8%
EPS	$102.99	$21.93	$108.78	$90.22	$10.05

Company Overview

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Visit Website

Earnings History & Surprises

OCPNF

Beat Rate

39%

Last 18 quarters

Avg Surprise

-5.7%

EPS vs Estimate

Beats / Misses

7/10

1 met exactly

Latest EPS

$0.12

Q4 2025

EPS Surprise History

Q3 23

-177.3%

$-0.13vs$0.17

Q1 24

-30.2%

$0.11vs$0.16

Q2 24

-60.8%

$0.04vs$0.11

Q3 24

-13.9%

$0.08vs$0.09

Q4 24

-8.8%

$0.20vs$0.22

Q1 25

-31.1%

$0.15vs$0.22

Q2 25

+60.7%

$0.25vs$0.16

Q4 25

-12.3%

$0.12vs$0.14

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 11, 2026	—	—	—	—
Q1 2026	Feb 12, 2026	—	—	—	—
Q4 2025	Nov 7, 2025	$0.14	$0.12	-12.3%	✗ MISS
Q2 2025	May 13, 2025	$0.16	$0.25	+60.7%	✓ BEAT
Q1 2025	Feb 12, 2025	$0.22	$0.15	-31.1%	✗ MISS
Q4 2024	Nov 8, 2024	$0.22	$0.20	-8.8%	✗ MISS
Q3 2024	Aug 7, 2024	$0.09	$0.08	-13.9%	✗ MISS
Q2 2024	May 10, 2024	$0.11	$0.04	-60.8%	✗ MISS
Q1 2024	Feb 14, 2024	$0.16	$0.11	-30.2%	✗ MISS
Q3 2023	Sep 30, 2023	$0.17	$-0.13	-177.3%	✗ MISS
Q3 2023	Aug 9, 2023	$1.33	$1.33	0.0%	= MET
Q1 2023	Mar 31, 2023	$0.24	$0.21	-10.1%	✗ MISS
Q1 2023	Feb 10, 2023	$0.24	$0.25	+4.1%	✓ BEAT
Q4 2022	Nov 11, 2022	$0.19	$0.23	+20.7%	✓ BEAT
Q3 2022	Aug 9, 2022	$0.15	$0.15	-5.5%	✗ MISS
Q2 2022	May 11, 2022	$0.11	$0.17	+62.0%	✓ BEAT
Q1 2022	Feb 4, 2022	$0.19	$0.17	-8.7%	✗ MISS
Q4 2021	Nov 5, 2021	$0.18	$0.30	+62.1%	✓ BEAT
Q3 2021	Aug 5, 2021	$0.10	$0.13	+35.7%	✓ BEAT
Q2 2021	May 7, 2021	$0.07	$0.08	+11.4%	✓ BEAT

Frequently Asked Questions about OCPNF

What is OCPNF's current stock price?

Olympus Corporation (OCPNF) is currently trading at $12.50 per share. The stock has moved +8.32% today.

What is the analyst price target for OCPNF?

No analyst price targets are currently available for this stock.

What sector is Olympus Corporation in?

Olympus Corporation operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is OCPNF's market cap?

Olympus Corporation has a market capitalization of $13.77 billion, making it a large-cap company.

Does OCPNF pay dividends?

No, Olympus Corporation does not currently pay a dividend to shareholders.